Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Vantiv Prices IPO At Midpoint Of Range

Payment processor Vantiv, Inc. (VNTV: Quote) said Wednesday that it has priced the initial public offering of 29.41 million shares of its Class A common stock at $17 per share, at the mid-point of the company's estimated range of $16 to $18 per share.

The Cincinnati, Ohio-based company said that its common stock will trade on the New York stock exchange under the ticker symbol "VNTV." Vantiv and the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 4.41 million shares to cover over-allotments, if any.

The company plans to contribute all of the net proceeds to Vantiv Holding, which will use the net proceeds to repay $460.8 million of the company's existing senior secured credit facilities.

However, the company will not receive any proceeds from the sale of shares by the selling stockholders.

Vantiv was spun off from Cincinnati, Ohio-based regional bank Fifth Third Bancorp. (FITB: Quote) in June 2009. Private equity firm Advent International Corp. currently holds a 51 percent stake in Vantiv, while Fifth Third holds a 49 percent stake.

In 2011, Vantiv's profit increased 65 percent from the prior year to $36.24 million, while revenue rose 40 percent to $1.62 billion.

According to the Nilson Report, Vantiv is the third-largest merchant acquirer and the largest PIN debt acquirer by transaction volume.

The report also notes that personal consumption expenditures in the U.S. using cards and other electronic payments reached $4.48 trillion in 2009 and are projected to reach $7.23 trillion in 2015. This represents a compound annual growth rate of about 8 percent during the period.

J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Credit Suisse Securities (USA) LLC are acting as lead joint book-running managers for the offering, while Goldman, Sachs & Co. and Deutsche Bank Securities Inc. are acting as joint book-running managers.

Citigroup Global Markets Inc., UBS Securities LLC, Jefferies & Company, Inc., Raymond James & Associates, Inc., William Blair & Company, L.L.C. and Wells Fargo Securities, LLC are acting as co-managers.

Register
To receive FREE breaking news email alerts for Vantiv, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.